Free Trial

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$5.54 +0.07 (+1.28%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$5.50 -0.04 (-0.81%)
As of 08/29/2025 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Biodexa Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/18/2025
8:28 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
08/18/2025
8:29 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
08/18/2025
8:29 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
08/18/2025
7:31 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2025
8:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/18/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/18/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:15 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/13/2025
3:19 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/02/2025
4:24 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/30/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
4:59 PM
Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
05/22/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/15/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
7:31 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
04/29/2025
3:15 PM
Biodexa Pharmaceuticals (Filer)
Form POS AM
04/17/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:41 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:43 AM
Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
3:30 PM
Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
02/13/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/22/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Buffett to put 90% of his money in this one stock? (Ad)

CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%.tc pixel

01/21/2025
5:27 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:30 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:18 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:21 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:24 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/17/2025
3:49 PM
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/17/2025
3:21 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:03 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:09 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:18 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/27/2024
4:15 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:56 AM
Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
Buffett to put 90% of his money in this one stock? (Ad)

CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%.tc pixel

09/19/2024
3:30 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BDRX) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners